Practical Smoking Cessation Allan Prochazka, M.D., M.Sc. Denver VAMC.

Slides:



Advertisements
Similar presentations
Nicotine Gum Nicotine absorbed mucosal membranes 2mg and 4mg strength
Advertisements

Case Examples.
Beating Joe Camel: The American Society of Anesthesiologists Smoking Cessation Initiative.
Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
I do not have any relevant financial relationships to disclose.
Question: Why should I quit? Answer: You will live longer and feel better. Quitting will lower your chances of having a heart attack, stroke, or cancer.
Tobacco Dependence Nancy A. Rigotti, M.D. Director, Tobacco Research & Treatment Center Massachusetts General Hospital Associate Professor of Medicine.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Presinted by :Shahd Amer.  Tobacco ads may make you feel like everyone is doing it but they are not.  Only about 28% of high school students smoke.
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
All About Smoking Cessation Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health.
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.
Introduction to Smoking Cessation MSSM III Edward Anselm, M.D. Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Medical Director,
SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
Tobacco Cessation: Curb the Deadliest Epidemic Keith Bradley, MD Director, Research Associates Program at St. Vincent’s National Alliance of Research Associates.
The Ohio Partners for Smoke-Free Families 5A’s
Quitting Smoking How to stop smoking … for good!.
Smoking Cessation Presented by Integrated Behavioral Health.
Insert your name and program name here
1 Basics of Tobacco Cessation Intervening with tobacco users in a systematic way, consistently identifying tobacco users and delivering an appropriate.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Nicotine-related disorders Answers obtained from DSM-IV-TR and the AJP Supplement of August, 2006, on substance abuse As of 1Sep08.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Smoking Cessation: the pharmacotherapeutic and non-pharmacotherapeutic approaches to addictive behavior Andrea C. McKean February 22, 2007.
Quit For Life® Program Presented by Helen Farid 1.
Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Getting Ready to Quit Course May,2011 Sponsored by: Baltimore County Health Department.
Tobacco Myths- Up in Smoke (American Cancer Society) HS 460.
TOBACCO CESSATION. SIDE EFFECTS OF TOBACCO USE Periodontal disease Heart Disease Cancer/Leukoplakia Bad breath Irritation Sores Decreased healing Cavities.
An Updated Algorithm for Choosing Among Smoking Cessation Treatments John R. Hughes University of Vermont, USA
Cherokee Health Systems Encouraging Tobacco Cessation Through the Five A’s: Ask, Advise, Assess, Assist, Arrange Mary Clare Champion, Ph.D. Cherokee Health.
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Tobacco Cessation Strategies and Resources: Epidemiology, Evidence and Availability May 29, 2013 The National Tobacco-Free College Campus Initiative: Building.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
SMOKING CESSATION Anju Mattoo, M.D..
Living Tobacco-Free It really is possible!. Agenda Statistics and mortality risks Health risks Benefits of quitting Ways to quit.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Tobacco Screening, Brief Intervention and Referral for Parents.
Better Health. No Hassles. Nicotine Dependence Addiction to tobacco products. Nicotine produces physical and mood-altering effects that are temporarily.
Using Standardized Patients to Teach Smoking Cessation Susan Stangl, MD, MSEd David Geffen School of Medicine at UCLA.
Journal #15 What does stimulant mean? What does Carcinogen mean?
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Types of help Available NHS Stop Smoking Services Nicotine Replacement Therapy (NRT) Other Pharmacological Treatments (non nicotine) Alternative Therapies.
1 Treating Nicotine Dependency Paul Zemann Public Health - Seattle & King County Tobacco Prevention Program th Ave, Suite 900 Seattle, WA 98104
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Lab 16. tobacco Nicotine Nicotine is the active ingredient in tobacco. Although this drug is not currently used therapeutically(except in smoking.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
Smoking cessation Supporting customers to quit. What you need to know PSA Presentation text 2 Discuss the health risks associated with smoking, and the.
Conclusions and Awards
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
Smoking Cessation Medication
Anita R. Webb, PhD JPS Family Medicine Residency
screening, brief intervention, and referral to treatment
Development and Implementation of a Tobacco Cessation Toolkit
Why and How to Quit Smoking
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Cessation Guidelines for COPD
Operant Conditioning – Chapter 8 Some Practical Applications…
ABCs of Behavioral Support
Tobacco Cessation for Primary Care Providers
Presentation transcript:

Practical Smoking Cessation Allan Prochazka, M.D., M.Sc. Denver VAMC

Outline 5 A’s Approach 5 A’s Approach –Ask –Advise –Assess –Assist –Arrange

AHQR Guidelines Released 6/00 Released 6/00 Based on review of > 3,000 studies Based on review of > 3,000 studies Nearly all are RCT’s Nearly all are RCT’s Probably the most evidence-based guideline in medicine Probably the most evidence-based guideline in medicine Resulted in the 5A’s approach Resulted in the 5A’s approach

Ask Ask all patients at each visit whether they smoke Ask all patients at each visit whether they smoke Why every visit? Why every visit? –Relapse among ex-smokers occurs even years after quitting Makes smoking salient for patients and providers Makes smoking salient for patients and providers Triggers quit attempts by patients and advice/interventions by providers Triggers quit attempts by patients and advice/interventions by providers

Implementation Electronic records Electronic records –VA is all electronic, reminders are automatically triggered, documentation of smoking status and advice is a performance measure for the hospital director Paper System Paper System »Decide who will be responsible and how one will track compliance

Advise Strongest data are for physician advice Strongest data are for physician advice –Other clinicians also likely to be effective Ideal to have a consistent approach across providers to reinforce the message Ideal to have a consistent approach across providers to reinforce the message –Patients will receive advice from multiple sources

Simple, direct message Simple, direct message –‘I’m your (doctor, nurse, therapist, health educator…) and the best thing you can do for your health is to quit smoking’ Avoid equivocation Avoid equivocation –‘You might want to think about someday perhaps considering quitting smoking’

Increasing Advice Effectiveness Link to patient’s health Link to patient’s health –Make the connection to other health problems »Asthma/Bronchitis/Emphysema »Heart disease »Reflux, ulcers »Skin changes »Vision—macular degeneration »Diabetes—accelerating effect of smoking on renal dysfunction, cardiovascular effects »Peripheral Vascular Disease

Use Ancillary Testing to Enhance Motivation to Quit –Pulmonary function testing and lung age »Portable units have greatly increased test quality »$500 - $1500, can be billed –Expired carbon monoxide testing »Instant feedback »No teaching required on meaning of CO »Low initial costs ($ )

Assess Identify willingness to quit Identify willingness to quit –Do you want to quit smoking? –If yes, when do you want to quit? »If ready now, then provide assistance on quitting at this visit and deal with other problems at the next visit »If not ready, then work on motivation and on barriers

Assess Identify Tobacco Dependence Identify Tobacco Dependence –DSM IV R criteria »Withdrawal with cessation »Smoking in the face of medical illness –Fagerstrom »How soon after awakening do you smoke your first cigarette? »If < 5 minutes, then highly dependent

Why bother with dependence? Why bother with dependence? –Reminder to providers –Identifies those who surely need more than advice –Reminder to patients when the diagnosis is shared with them

Increasing Motivation Relevance Relevance Risks Risks Rewards Rewards Roadblocks Roadblocks Repetition Repetition

Relevance Relevance –Personalize the effects of smoking –Consider influence on family members (e.g. parents smoking aggravating child’s asthma) Risks Risks –Generic risks are not as influential as personal risk –Short term risks are more salient than long term risks, especially for young people –Risks without benefits, sometimes lead to paralysis, so emphasize the improvements that are possible

Rewards Personal Personal –Taste/smell improve –Clothes, home, breath smell better Health Health –Improvement in current medical conditions –Avoidance of complications Economic Economic –Out of pocket costs of smoking can be significant expense for those on fixed income Social Social –Example for children –Self-control, mastery

Roadblocks Weight gain Weight gain Fear of failure Fear of failure Withdrawal symptoms Withdrawal symptoms Lack of support from family/friends Lack of support from family/friends ‘The only thing I have left is smoking’ ‘The only thing I have left is smoking’

Repetition Key point is that messages need to be repeated over time Key point is that messages need to be repeated over time A person may not be ready to take action today, that doesn’t mean he/she won’t be ready next week, next month or next year A person may not be ready to take action today, that doesn’t mean he/she won’t be ready next week, next month or next year Smokers also need to know that relapse after a quit attempt is normal, most will need several solid efforts to be successful Smokers also need to know that relapse after a quit attempt is normal, most will need several solid efforts to be successful

Assist Behavioral Behavioral Drug Therapy Drug Therapy Smokers wanting to quit need both Smokers wanting to quit need both Dose of each one can be tailored to the patient’s needs Dose of each one can be tailored to the patient’s needs

Behavioral Key element is time with patient and empathic counselor Key element is time with patient and empathic counselor More time, more benefit, but get results even with small investments More time, more benefit, but get results even with small investments Goals Goals –Set a quit date –Tell family, friends, coworkers –Make the home smoke free, start acting like a non- smoker –Identify barriers to cessation

Goal: total abstinence after quit day Goal: total abstinence after quit day Review prior quit attempts, learn from them Review prior quit attempts, learn from them Anticipate triggers and challenges Anticipate triggers and challenges Encourage others in the home to quit Encourage others in the home to quit Provide options Provide options –Referral –Quitline –Self-help materials

Drug Therapy Nicotine Replacement Therapy (NRT) Nicotine Replacement Therapy (NRT) –Nicotine Gum –Nicotine Patch –Nicotine Nasal Spray –Nicotine Inhaler –Nicotine Lozenge Non-Nicotine Therapy Non-Nicotine Therapy –Bupropion (Zyban)

NRT Overall success rate comparable among the products Overall success rate comparable among the products Doubles the quit rate over advice alone Doubles the quit rate over advice alone –(e.g. 5-8% to 10-15%) Selection based on side effects, patient preference, insurance coverage Selection based on side effects, patient preference, insurance coverage PDR duration of therapy 8-12 weeks PDR duration of therapy 8-12 weeks Selected patients need longer therapy or higher doses Selected patients need longer therapy or higher doses

Nicotine Gum 2 forms (2 mg and 4mg), 4 mg best for most smokers 2 forms (2 mg and 4mg), 4 mg best for most smokers Available OTC and in Generic forms Available OTC and in Generic forms Absorption is buccal, so park and chew Absorption is buccal, so park and chew Regular dosing better than ad lib Regular dosing better than ad lib Typical patient will use 5-8 pieces per day Typical patient will use 5-8 pieces per day Cost $35-50 for 108 pieces Cost $35-50 for 108 pieces

Side Effects Side Effects –Dental trauma, jaw pain, nausea, upset stomach Duration of Use Duration of Use –8-12 weeks –2-5% have trouble quitting gum –Long term use combined with behavioral therapy (up to 5 years) safe and effective, 25% validated quit rate in Lung Health Study

Transdermal Nicotine 3 strengths (21, 14, 7 mg/24hr) 3 strengths (21, 14, 7 mg/24hr) Some patients require higher doses (e.g. very heavy smokers), but for typical pack a day smoker 21mg is the starting dose Some patients require higher doses (e.g. very heavy smokers), but for typical pack a day smoker 21mg is the starting dose 4-6 weeks on 21 mg, 2-4 weeks on 14 mg, then 2-4 weeks on 7 mg 4-6 weeks on 21 mg, 2-4 weeks on 14 mg, then 2-4 weeks on 7 mg Costs $35-50 per 14 day supply Costs $35-50 per 14 day supply

Side Effects Side Effects –Skin irritation (30%) –Skin allergy (1-4%) –Poor sleep/nightmares (10%) –Arm pain (2-4%)

Nasal Nicotine Spray Very rapid absorption of nicotine Very rapid absorption of nicotine Dosing 0.5 mg per spray, one spray in each nostril is one dose (about the amount of nicotine in one cigarette) Dosing 0.5 mg per spray, one spray in each nostril is one dose (about the amount of nicotine in one cigarette) Typical patient uses 3-6 doses per day Typical patient uses 3-6 doses per day Side Effects: mostly irritation, face pain, perhaps more likely to result in difficulty stopping use due to fast absorption Side Effects: mostly irritation, face pain, perhaps more likely to result in difficulty stopping use due to fast absorption Costs $46.99 per 10 ml vial (100 doses) Costs $46.99 per 10 ml vial (100 doses)

Nicotine Inhaler Each cartridge 10 mg nicotine, 4 mg released, 2 mg absorbed Each cartridge 10 mg nicotine, 4 mg released, 2 mg absorbed Best with continuous puffing (80 deep inhalations over 20 minutes give 2 mg nicotine) Best with continuous puffing (80 deep inhalations over 20 minutes give 2 mg nicotine) Dosage 6-16 cartridges per day Dosage 6-16 cartridges per day Side Effects: mouth/nose irritation Side Effects: mouth/nose irritation Costs $51.69 per 42 cartridges Costs $51.69 per 42 cartridges

Nicotine Lozenge Approved 11/02 Approved 11/02 Available OTC, 2 mg and 4 mg Available OTC, 2 mg and 4 mg Allow lozenge to slowly dissolve, no chewing or swallowing of the lozenge—need to be careful not to develop too much saliva Allow lozenge to slowly dissolve, no chewing or swallowing of the lozenge—need to be careful not to develop too much saliva minutes per lozenge minutes per lozenge Dose 20 max per day Dose 20 max per day Side effects: hiccups, nausea, stomach upset, palpitations Side effects: hiccups, nausea, stomach upset, palpitations Cost $42.00 for box of 72 lozenges Cost $42.00 for box of 72 lozenges

Non-Nicotine Therapy Bupropion (Zyban) Bupropion (Zyban) Antidepressant, works in normal, non- depressed smokers Antidepressant, works in normal, non- depressed smokers Slower onset of action (7-10 days) Slower onset of action (7-10 days) Dosage: 150 mg a day for 3 days, then 150 mg bid, but not much difference in effectiveness between 150 and 300 mg /day Dosage: 150 mg a day for 3 days, then 150 mg bid, but not much difference in effectiveness between 150 and 300 mg /day Duration: 3 months, but longer term therapy is safe and effective Duration: 3 months, but longer term therapy is safe and effective

Costs VA $53 for one month Costs VA $53 for one month Side Effects Side Effects –Common »Shaky,tremor »Headache »Dry mouth –Rare but serious »Seizures »Avoid in those with epilepsy, active drug use, concomitant psychiatric medications, bulemia, MAOI use

Combined with NRT Combined with NRT –Borderline significance, but 9% better with patch combined with bupropion Very useful in healthy populations (e.g. worksite) and in those with active cardiac disease Very useful in healthy populations (e.g. worksite) and in those with active cardiac disease Hard to use in populations with lots of psychiatric comorbidity/substance abuse due to risk of seizures, precipitation of mania and need to add to already complex drug regimens Hard to use in populations with lots of psychiatric comorbidity/substance abuse due to risk of seizures, precipitation of mania and need to add to already complex drug regimens May be better in those with a depressive tendency May be better in those with a depressive tendency Less weight gain than with patch Less weight gain than with patch

Has been tested in several populations including patients with COPD, African Americans; effect appears to be robust Has been tested in several populations including patients with COPD, African Americans; effect appears to be robust Bottom Line: very useful agent for many populations Bottom Line: very useful agent for many populations

Arrange Followup greatly enhances cessation results Followup greatly enhances cessation results Can be in person or on the telephone Can be in person or on the telephone Linkage to Quitline in Colorado and other states may allow more intensive followup that would usually be available in primary care settings Linkage to Quitline in Colorado and other states may allow more intensive followup that would usually be available in primary care settings

Congratulate on success Congratulate on success Review lapses Review lapses Emphasize total abstinence Emphasize total abstinence Review drug therapy Review drug therapy Consider referral if needed Consider referral if needed

Cost Effectiveness $ per QALY No NRT NRT Brief Individual Intensive Group Intensive

Conclusions Implement the 5A’s Implement the 5A’s Use combined drug and behavioral approaches Use combined drug and behavioral approaches Select drugs based on patient preference and associated medical conditions Select drugs based on patient preference and associated medical conditions Followup and allow patients to recycle Followup and allow patients to recycle Make a long term commitment Make a long term commitment